JP Business

Unilever all but drops bid for GSK consumer arm

Unilever on Wednesday effectively abandoned its plans to buy GlaxoSmithKline's consumer healthcare business, saying that it would not raise a 50 billion pound ($68 billion) offer that GSK previously rejected. Francis Maguire reports.